191 related articles for article (PubMed ID: 17970785)
21. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
22. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L; Bergmann C; Whiteside TL
Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
[TBL] [Abstract][Full Text] [Related]
23. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
24. Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.
Tiemessen MM; Mitchell TJ; Hendry L; Whittaker SJ; Taams LS; John S
J Invest Dermatol; 2006 Oct; 126(10):2217-23. PubMed ID: 16741512
[TBL] [Abstract][Full Text] [Related]
25. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.
Hoffmann P; Eder R; Boeld TJ; Doser K; Piseshka B; Andreesen R; Edinger M
Blood; 2006 Dec; 108(13):4260-7. PubMed ID: 16917003
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.
Maker AV; Attia P; Rosenberg SA
J Immunol; 2005 Dec; 175(11):7746-54. PubMed ID: 16301685
[TBL] [Abstract][Full Text] [Related]
27. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
[TBL] [Abstract][Full Text] [Related]
28. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
29. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
[TBL] [Abstract][Full Text] [Related]
30. IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3.
Imamichi H; Sereti I; Lane HC
Eur J Immunol; 2008 Jun; 38(6):1621-30. PubMed ID: 18493981
[TBL] [Abstract][Full Text] [Related]
31. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
32. HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.
Satou Y; Utsunomiya A; Tanabe J; Nakagawa M; Nosaka K; Matsuoka M
Retrovirology; 2012 May; 9():46. PubMed ID: 22647666
[TBL] [Abstract][Full Text] [Related]
33. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
[TBL] [Abstract][Full Text] [Related]
34. Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells.
Chen S; Ishii N; Ine S; Ikeda S; Fujimura T; Ndhlovu LC; Soroosh P; Tada K; Harigae H; Kameoka J; Kasai N; Sasaki T; Sugamura K
Int Immunol; 2006 Feb; 18(2):269-77. PubMed ID: 16361311
[TBL] [Abstract][Full Text] [Related]
35. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation.
Sugita S; Ng TF; Schwartzkopff J; Streilein JW
J Immunol; 2004 Apr; 172(7):4184-94. PubMed ID: 15034031
[TBL] [Abstract][Full Text] [Related]
36. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
37. Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival.
Dobrzanski MJ; Rewers-Felkins KA; Quinlin IS; Samad KA; Phillips CA; Robinson W; Dobrzanski DJ; Wright SE
Clin Immunol; 2009 Dec; 133(3):333-52. PubMed ID: 19762283
[TBL] [Abstract][Full Text] [Related]
38. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
39. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H
Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483
[TBL] [Abstract][Full Text] [Related]
40. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
